Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Depreciation Expense (2016 - 2019)

Xtant Medical Holdings has reported Depreciation Expense over the past 10 years, most recently at $800000.0 for Q3 2019.

  • Quarterly Depreciation Expense changed 0.0% to $800000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Sep 2019, up 34.78% year-over-year, with the annual reading at $3.2 million for FY2018, 15.79% down from the prior year.
  • Depreciation Expense was $800000.0 for Q3 2019 at Xtant Medical Holdings, up from $700000.0 in the prior quarter.
  • Over five years, Depreciation Expense peaked at $2.0 million in Q3 2017 and troughed at -$100000.0 in Q4 2017.
  • The 5-year median for Depreciation Expense is $747850.0 (2016), against an average of $653061.0.
  • Year-over-year, Depreciation Expense plummeted 139.99% in 2017 and then skyrocketed 900.0% in 2018.
  • A 5-year view of Depreciation Expense shows it stood at $112750.0 in 2015, then surged by 121.8% to $250078.0 in 2016, then plummeted by 139.99% to -$100000.0 in 2017, then skyrocketed by 900.0% to $800000.0 in 2018, then changed by 0.0% to $800000.0 in 2019.
  • Per Business Quant, the three most recent readings for XTNT's Depreciation Expense are $800000.0 (Q3 2019), $700000.0 (Q2 2019), and $800000.0 (Q1 2019).